O

Odonate Therapeutics Inc
OTC:ODTC

Watchlist Manager
Odonate Therapeutics Inc
OTC:ODTC
Watchlist
Price: 50 000 USD Market Closed
Market Cap: 52.7m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ODTC.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ODTC Intrinsic Value
Not Available
O
Base Case Scenario
Compare ODTC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Odonate’s single-asset pipeline—centered on Tesetaxel—amplifies uncertainty, as any major setback in clinical trials or regulatory reviews could dramatically limit the company’s future prospects and valuation.

Limited commercialization infrastructure and dependence on licensing or partnership agreements increase Odonate’s expenditures while offering no guaranteed revenue source, eroding cash reserves without near-term top-line contributions.

Rival oncology therapies from larger, well-capitalized competitors pose a significant threat, reducing Odonate’s ability to capture market share, and potentially undermining the viability of Tesetaxel in the broader breast cancer treatment landscape.

Bull Theses

If Tesetaxel gains approval and demonstrates meaningful clinical benefits over existing therapies, Odonate could capture a lucrative niche in the breast cancer market, driving substantial revenue growth.

Odonate’s lean operating model and focus on a singular high-potential therapy position it for efficient cost management, potentially enhancing returns if Tesetaxel successfully clears pivotal trials.

Positive clinical data and a clear regulatory path could attract partnership or acquisition interest from larger pharma companies, offering a significant upside for shareholders in both the near and long term.

Show More Less
How do you feel about ODTC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Odonate Therapeutics Inc

Current Assets 99.6m
Cash & Short-Term Investments 95m
Other Current Assets 4.6m
Non-Current Assets 6.2m
PP&E 5.4m
Other Non-Current Assets 768k
Current Liabilities 30.3m
Accounts Payable 11.7m
Accrued Liabilities 18.6m
Non-Current Liabilities 4.1m
Other Non-Current Liabilities 4.1m
Efficiency

Free Cash Flow Analysis
Odonate Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Odonate Therapeutics Inc

Revenue
0 USD
Operating Expenses
-90.7m USD
Operating Income
-90.7m USD
Other Expenses
-11.4m USD
Net Income
-102.1m USD
Fundamental Scores

ODTC Profitability Score
Profitability Due Diligence

Odonate Therapeutics Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROE is Increasing
Low 3Y Average Gross Margin
50/100
Profitability
Score

Odonate Therapeutics Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ODTC Solvency Score
Solvency Due Diligence

Odonate Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Odonate Therapeutics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ODTC Price Targets Summary
Odonate Therapeutics Inc

There are no price targets for ODTC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Odonate Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ODTC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ODTC Insider Trading
Buy and sell transactions by insiders